ALNY
Alnylam Pharmaceuticals, Inc.
$293.66
-0.33%
-0.99
Notify me if price changes either direction
Buy ALNY stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
39.4B
Enterprise value
39.4B
Trailing PE
74.13316
Forward PE
21.266151
PEG Ratio
-0.16391251457286
Enterprise to EBITDA
48.769
Enterprise to revenue
9.18
Price to book MRQ
36.61124
Price to sales TTM
9.189081
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2026-03-31
Revenue (TTM)
4.3B
EBITDA
909.4M
Diluted EPS TTM
3.98
Total Cash (MRQ)
3.0B
Current ratio (MRQ)
3.127
Operating Cash Flow (TTM)
714.9M
ALNY trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
May 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
